TrialSite’s coverage in the past year includes the ongoing research and development associated with France-based MedinCell, the biotech developing several long-acting injectable formulations of ivermectin.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.